ERITO-5 – Escitalopram 5mg Tablets | PCD Pharma Franchise
Escitalopram is the S-enantiomer of citalopram, isolated specifically because it's the more active half of the molecule at the serotonin transporter. That's why Escitalopram doses run lower than citalopram doses for a comparable effect. ERITO-5 delivers 5mg per tablet, manufactured by Akums.
At a Glance
Escitalopram 5mg — Selective Serotonin Reuptake Inhibitor (SSRI)
S-enantiomer of citalopram, more selective at the serotonin transporter
Used in depression and anxiety-spectrum disorders
Manufactured by Akums
Schedule H — prescription only
Open for PCD Pharma Franchise across India
Composition
Escitalopram — 5 mg — Selective Serotonin Reuptake Inhibitor (SSRI); increases serotonin availability at the synapse by blocking its reuptake
Pharmacological Class
Escitalopram works by selectively blocking the reuptake of serotonin at the presynaptic neuron, increasing its availability in the synaptic cleft. As the isolated S-enantiomer of citalopram, it binds the serotonin transporter more selectively than the racemic mixture, which is the basis for its use at lower milligram doses. The 5mg strength is commonly used as a starting dose, particularly in patients beginning treatment or those more sensitive to SSRI side effects.
Indications / Areas of Use
- Major depressive disorder
- Generalized anxiety disorder
- Panic disorder
- Social anxiety disorder
Use, dose, and duration are determined by the prescribing psychiatrist or physician based on individual clinical assessment.
Who Typically Prescribes ERITO-5
Psychiatrists prescribe it across depressive and anxiety-spectrum disorders, often starting at the 5mg dose before titrating upward. General Physicians also prescribe it within their scope, particularly for anxiety presentations, and refer for specialist management where indicated.
Dosage & Administration
As prescribed by a Registered Medical Practitioner. This is a Schedule H drug — sale by retail is permitted only against the prescription of a Registered Medical Practitioner. Dose is typically titrated gradually under medical supervision. Not for self-medication.
Safety Information
Escitalopram should not be combined with MAOI antidepressants. It should not be stopped abruptly, as this can cause discontinuation symptoms — any change in dose should be physician-guided. As with all SSRIs, close monitoring is recommended in the early weeks of treatment, particularly in younger patients, for any worsening of mood or emergence of self-harm-related thoughts, and any such changes should be reported to the prescribing doctor immediately. Store below 25°C, protect from light and moisture. Keep out of reach of children.
Patient Counselling Points
- Full therapeutic effect can take several weeks — response shouldn't be judged in the first few days
- Never stop or reduce the dose without consulting the prescribing physician
- Avoid alcohol during treatment
- Report any worsening mood, agitation, or unusual thoughts to the doctor promptly
- Inform the physician of all other medications, particularly other serotonergic drugs
Why ERITO-5 from Eridanus Healthcare
ERITO-5 is manufactured by Akums, one of India's largest and most established pharmaceutical manufacturers, at a WHO-GMP certified facility. It's open for PCD Pharma Franchise across India, with monopoly basis rights available in select states.
Frequently Asked Questions
What is ERITO-5 used for?
ERITO-5 contains Escitalopram 5mg, used in the management of depression, generalized anxiety disorder, panic disorder and social anxiety disorder, as prescribed by a registered medical practitioner.
Why is the Escitalopram dose lower than a typical citalopram dose?
Escitalopram is the more selective, active isolated half of the citalopram molecule, so a lower milligram dose achieves a comparable effect.
Can ERITO-5 be stopped as soon as symptoms improve?
No. SSRIs like Escitalopram should never be stopped abruptly, and any change in treatment should be guided by the prescribing physician to avoid discontinuation symptoms.
Who manufactures ERITO-5?
ERITO-5 is manufactured by Akums at a WHO-GMP certified facility, and marketed by Eridanus Healthcare.
Is ERITO-5 available for PCD Pharma Franchise?
Yes. ERITO-5 is open for PCD Pharma Franchise across India under Eridanus Healthcare, with monopoly basis rights available in select states.
Disclaimer: This information is provided for general knowledge purposes only and is not a substitute for professional medical advice. This is a Schedule H drug — to be sold by retail only on the prescription of a Registered Medical Practitioner. If you or someone you know is experiencing thoughts of self-harm, seek immediate help from a doctor, mental health professional, or emergency services. Please consult a registered medical practitioner before taking this or any medication.